Hard Tech Venture Capital

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

Event Details
  • Date/Time:
    • Thursday February 16, 2023
      11:00 am - 12:00 pm
  • Location: Kendeda Building Auditorium, 422 Ferst Drive NW, Atlanta GA
  • Phone:
  • URL:
  • Email:
  • Fee(s):
    N/A
  • Extras:
Contact
No contact information submitted.
Summaries

Summary Sentence: Andrew Gollach, MBA, Principal at HAX/SOSV

Full Summary: No summary paragraph submitted.

Learn how venture capitalists decide to invest with hard-tech, medical devices, and diagnostic seed funds for SOSV Ventures.

Andrew Gollach, MBA
Principal
HAX, Hard Tech Venture Capital

Lunch provided.

Additional Information

In Campus Calendar
Yes
Groups

GT Commercialization, Parker H. Petit Institute for Bioengineering and Bioscience (IBB)

Invited Audience
Faculty/Staff, Postdoc, Public, Graduate students, Undergraduate students
Categories
Seminar/Lecture/Colloquium
Keywords
go-bio-commercialization, go-bio
Status
  • Created By: Christina Wessels
  • Workflow Status: Published
  • Created On: Feb 14, 2023 - 10:00am
  • Last Updated: Feb 14, 2023 - 10:54am